(Total Views: 492)
Posted On: 06/25/2019 10:05:40 AM
Post# of 106729

$RFL News Article - Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613 (devimistat) in Japan and Other Asian Countries https://marketwirenews.com/news-releases/rafa...09954.html


My Twitter: WhyteStocks